Antiverse
The company specializes in designing antibodies for challenging biological targets using computational and engineering approaches. Its technology platform is used to identify and develop therapeutic candidates for the drug discovery industry. The firm operates out of the sbarc|spark facility in Cardiff to support its research and development activities.
Biotechnology
Drug Discovery
Healthtech
Funding summary
- Total raised
- €16.7M
- Funding rounds
- 4
Investors in Antiverse
Investors on record for Antiverse. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Antiverse?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors